key: cord-0940221-84ov8y4v
authors: Morais-Almeida, Mário; Sousa, Cláudia S.; Barbosa, Miguel T.; Aguiar, Rita; Benito-Garcia, Filipe
title: Telehealth: the future is now in allergy practice
date: 2020-07-09
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2020.06.044
sha: f0fbde97e3e1d47514171679d97e5bf7dcd750d7
doc_id: 940221
cord_uid: 84ov8y4v

nan

To the Editor, 21 We read with interest the Editorial by Portnoy et al, 1 where the authors in the face of 22 the current pandemic very elegantly summarize the main advantages and limitations 23 of virtual appointments. Telemedicine (TM) has the potential to help enabling patients 24 to get the supportive care they need, and the use of this tool is increasing. 2 We agree 25 with the authors that a pandemic is an unfortunate occurrence but it is also an 26 opportunity to set up an infrastructure for providing care using TM, that can continue 27 to be used in the future to provide convenient and cost-effective care to patients. 1 Patients were invited to be consulted in virtual visits, including first appointments (12% 40 of the total). We noted an increasing agreement to virtual visits (figure), followed by a 41 decrease when emergency state was over on May 2 nd . For these consultations, 42 patients only had to have internet connection and a smartphone, tablet or computer 43 with camera and microphone. All the prescriptions and treatment plans were also sent 44 virtually. When indicated we still received the more severe patients as in-person visits, 45 in particular patients with specific needs, including desensitization to chemotherapy. 46 In order to assess satisfaction and willingness to repeat or recommend virtual 47 appointments, we conducted two surveys, one for patients with asthma (n=40) that 48 had participated in virtual consultations during this pandemic (with the collaboration 49 of the Portuguese Association of Asthmatics) and another one for the allergy 50 specialists of our center (n=21). 51 In summary, communication between patient and doctors was not considered to be 52 compromised in virtual appointments (>92% agreement in both surveys). Most 53 patients rated the virtual visit as good/very good (93%). Ninety-five percent of the 54 providers considered that their performance was not affected but 43% had some 55 difficulties in the management of their patients, mainly related to the lack of physical 56 examination. Seventy percent of patients would adhere to these appointments outside 57 COVID-19, and 93% would recommend it to their family and friends. Doctors consider 58 that this way of practicing medicine has a future in our healthcare system (93%), 59 benefiting from mild to severe patients (81%), as well as those living far away from the 60 hospital (19%). Less than 5% of the patients needed to be referred to do in-person 61 visits. 62 Telemedicine is an already validated tool. [1] [2] [3] [4] The COVID-19 pandemic allowed us to 63 implement telehealth-focused processes to provide safe and convenient patient care, 64 and both patients and allergists seem willing to continue to use it. 

Telemedicine in the Era of COVID-19

Telemedicine and emerging technologies 78 for health care in allergy/immunology

Tele-medicine in respiratory diseases

Telemedicine is as effective as in-person 82 visits for patients with asthma

Telemedicine in a post-COVID world: How eConsults can be used to 84 augment an allergy practice

Figure -Distribution of in-person and real-time video-virtual visits at the Allergy Center 89 of CUF Descobertas Hospital since the first week of March (10th week). The virtual 90 visits were implemented in the 14th week